Literature DB >> 3032037

Cryptococcal meningitis and fluconazole.

B Dupont, E Drouhet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3032037     DOI： 10.7326/0003-4819-106-5-778_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  16 in total

1.  The pharmacokinetics of fluconazole during haemodialysis in uraemic patients.

Authors:  S Oono; K Tabei; T Tetsuka; Y Asano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes.

Authors:  F Dromer; J Barbet; J Bolard; J Charreire; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.

Authors:  G S Kobayashi; S J Travis; M G Rinaldi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

4.  Sputum levels of fluconazole in humans.

Authors:  P Ebden; P Neill; P R Farrow
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 5.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

6.  Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.

Authors:  D Pappagianis; B L Zimmer; G Theodoropoulos; M Plempel; R F Hector
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 7.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

8.  Antifungal properties of essential oils and their main components upon Cryptococcus neoformans.

Authors:  C Viollon; J P Chaumont
Journal:  Mycopathologia       Date:  1994-12       Impact factor: 2.574

9.  Efficacy of fluconazole in the treatment of systemic fungal infections.

Authors:  D Milatovic; A Voss
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

Review 10.  Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.

Authors:  F N Vincent-Ballereau; O N Patey; C Lafaix
Journal:  Pharm Weekbl Sci       Date:  1991-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.